Alzheimer's disease
Disease
|
Physical therapy...who have a neurological disorder or disease. These include Alzheimer's disease, ALS , brain injury, cerebral palsy, multiple sclerosis, Parkinson's disease, spinal cord injury, and stroke. Common impairments associated with neurologic... In this article: Physical therapy, Orthopedic surgery, Massage, Manual therapy, Cerebral palsy, Arthritis, Alzheimer's disease, and United States |
-
GlobalPost | October 13, 2009
Under threat in India: mothers-in-law?
...10, 2009 12:19 ET A controversial New Delhi clinic deploys advanced therapies that are unavailable in the U.S. to cure Americans suffering from MS, diabetes, paralysis, Alzheimer's, Lyme disease and cerebral palsy. Jason Overdorf - India...
In this article: India, Bangalore, Suicide, Cerebral palsy, Alzheimer's, Paralysis, and Lyme disease
-
Wikipedia | September 15, 2009
Patricia Goldman-Rakic
...frontal cortex. Because of Goldman-Rakic, scientists began to better understand the neurobiological basis of normal behavior and of such disorders as schizophrenia, Alzheimer's, A.D.D., cerebral palsy, Parkinson's, and dementia. She used a...
In this article: Patricia Goldman-Rakic, University of California at Los Angeles, National Institute of Mental Health, Multidisciplinary approach, Dementia, Cerebral palsy, Alzheimer's, Yale School of Medicine, New York University, and Columbia University
-
GlobalPost | October 09, 2009
Unfettered by regulation, India pulls ahead on stem cell treatments
...by the use of a single donated embryo, she has been able to treat 600 patients for conditions such as Alzheimer's, multiple sclerosis, renal failure, cerebral palsy, and diabetes. What's also unique about Dr. Shroff's technique is that's she's...
In this article: India, Indian Council of Medical Research, Cerebral palsy, U.S., and Physical therapy
-
Scientific American - Full Content | June 30, 2008
Alzheimer's Drug May Prevent Brain Damage in Preemies: Scientific American
Alzheimer's Drug May Prevent Brain Damage in Preemies: Scientific American Alzheimer's Drug May Prevent Brain Damage in Preemies Medication that slows progression of dementia may also reverse injury that causes cerebral palsy in preterm...
In this article: Stroke, Oxygen, Memantine, Brain damage, Cerebral palsy, Scientific American, and Dementia
-
Contactmusic.com | May 11, 2009
Family Of Munchkin Carroll Sues Over Estate
The star, born Michael Finocchiaro, had been suffering from Alzheimer's disease and his relatives claim he was not mentally fit when he signed over control of his assets to carer Linda Dodge four months before his death. Dodge...
In this article: Allegation, All rights reserved, Cerebral palsy, and St. Louis, Missouri
-
www.washingtonpost.com | February 04, 2007
Health Highlights: Feb. 5, 2007
...ofHealthDay: Gene Increases Risk of Cerebral Palsy A form of a gene -- apoliprotein E (APOE) -- that increases the risk of Alzheimer's disease in adults can also increase the likelihood of cerebral palsy in brain-injured newborns, say...
In this article: Cerebral palsy, Vitamin, HIV, Richard Blumenthal, Respondent, Caffeine, and AIDS
-
MedicineNet | December 03, 2008
Bogus Stem Cell Therapies Sold on Internet
...have treated thousands of patients for neurological disorders including multiple sclerosis, Parkinson's disease, spinal cord injury and Alzheimer's disease, congenital conditions such as autism and cerebral palsy, as well as allergies, heart...
In this article: Neurosurgery, Allergy, Parkinson's disease, Case Western Reserve University School of Medicine, Cleveland, and Tampa, Florida
-
www.washingtonpost.com | June 23, 2008
Alzheimer's Drug May Reduce Preemie Brain Injury
...Brain Injury TUESDAY, June 24 (HealthDay News) -- The Alzheimer's drug memantine (brand name Namenda) may help reduce a form of brain injury that affects many premature babies, according to a Children's Hospital Boston study.
In this article: Memantine, Alzheimer's, Brain Injury, Children's Hospital Boston, Oxygen, Cerebral palsy, Periventricular leukomalacia, and NMDA Receptor
-
Medical News Today | March 06, 2008
Report On 547 New Medicines In Development For Neurological Disorders Released In San Antonio
...will enable patients to live longer, healthier, and more productive lives." The neurological medicines in development include 82 for Alzheimer's disease, 26 for epilepsy, 23 for stroke, 30 for Parkinson's disease, 58 for brain tumors, 46...
In this article: San Antonio, Texas, Parkinson's disease, Epilepsy, Pharmaceutical Research and Manufacturers of America, Dementia, and Cerebral palsy
Trends
Loading...
More on Alzheimer's disease
Description from Wikipedia:
Alzheimer's disease (AD), also called Alzheimer disease or simply Alzheimer's, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German psychiatrist Alois Alzheimer in 1901. Generally it is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer's can occur much earlier. An estimated 26.6 million people worldwide were afflicted with Alzheimer's in 2006; this number may quadruple by 2050.
Although each sufferer experiences Alzheimer's in a unique way, there are many common symptoms. The earliest observable symptoms are often mistakenly thought to be 'age-related' concerns, or manifestations of stress. In the early stages, the most commonly recognised symptom is memory loss, such as difficulty in remembering recently learned facts. When a doctor or physician has been notified, and AD is suspected, the diagnosis is usually confirmed with behavioural assessments and cognitive tests, often followed by a brain scan if available. As the disease advances, symptoms include confusion, irritability and aggression, mood swings, language breakdown, long-term memory loss, and the general withdrawal of the sufferer as their senses decline. Gradually, bodily functions are lost, ultimately leading to death. Individual prognosis is difficult to assess, as the duration of the disease varies. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years. The mean life expectancy following diagnosis is approximately seven years. Fewer than three percent of individuals live more than fourteen years after diagnosis.
Explore everything named Alzheimer's disease...